Cargando…
Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for Neuroprotection
Achieving neuroprotection in ischemic stroke patients has been a multidecade medical challenge. Numerous clinical trials were discontinued in futility and many were terminated in response to deleterious treatment effects. Recently, however, several positive reports have generated the much-needed exc...
Autores principales: | Yeh, Chung-Yang, Schulien, Anthony J., Molyneaux, Bradley J., Aizenman, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503403/ https://www.ncbi.nlm.nih.gov/pubmed/32854248 http://dx.doi.org/10.3390/ijms21176107 |
Ejemplares similares
-
Targeted disruption of Kv2.1-VAPA association provides neuroprotection against ischemic stroke in mice by declustering Kv2.1 channels
por: Schulien, Anthony J., et al.
Publicado: (2020) -
Regulation of Pro-Apoptotic Phosphorylation of Kv2.1 K(+) Channels
por: He, Kai, et al.
Publicado: (2015) -
Ischemic Stroke and Neuroprotection
por: Onwuekwe, IO, et al.
Publicado: (2012) -
Recent Advances in Childhood Arterial Ischemic Stroke
por: Fox, Christine K., et al.
Publicado: (2010) -
Neuroprotection for Nonarteritic Central Retinal Artery Occlusion: Lessons from Acute Ischemic Stroke
por: Okonkwo, Ogugua Ndubuisi, et al.
Publicado: (2023)